QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode

Effect of QiShenYiQi Pill on Myocardial Collagen Metabolism in Rats with Partial Abdominal Aortic Coarctation

(2015) Shichao Lv et al.   Evidence-based Complementary and Alternative Medicine

The role of Pyruvate Dehydrogenase Complex in cardiovascular diseases

(2015) Wanqing Sun et al.   LIFE SCIENCES

Baicalein Attenuates Angiotensin II-Induced Cardiac Remodeling via Inhibition of AKT/mTOR, ERK1/2, NF-κB, and Calcineurin Signaling Pathways in Mice

(2014) Ai-Wu Wang et al.   AMERICAN JOURNAL OF HYPERTENSION

Danshensu Inhibits β-Adrenergic Receptors-Mediated Cardiac Fibrosis by ROS/p38 MAPK Axis

(2014) Haiyan Lu et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Redox regulation of cardiac hypertrophy

(2014) Can M. Sag et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Qishenyiqi Protects Ligation-Induced Left Ventricular Remodeling by Attenuating Inflammation and Fibrosis via STAT3 and NF-κB Signaling Pathway

(2014) Chun Li et al.   PLoS One

Protective effects of Notoginsenoside R1 on intestinal ischemia-reperfusion injury in rats

(2013) Chong Li et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Absorption, metabolism and effect of compatibility on absorption of qishenyiqi dropping pill

(2013) Yan-qi Han et al.   BIOMEDICAL CHROMATOGRAPHY

QSYQ Attenuates Oxidative Stress and Apoptosis Induced Heart Remodeling Rats through Different Subtypes of NADPH-Oxidase

(2013) Yong Wang et al.   Evidence-based Complementary and Alternative Medicine

QiShenYiQi Pills, a Compound Chinese Medicine, Ameliorates Doxorubicin-Induced Myocardial Structure Damage and Cardiac Dysfunction in Rats

(2013) Dong-Xin Tang et al.   Evidence-based Complementary and Alternative Medicine

Signaling effectors underlying pathologic growth and remodeling of the heart

(2013) Jop H. van Berlo et al.   JOURNAL OF CLINICAL INVESTIGATION

Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy

(2013) Juan Yang et al.   JOURNAL OF ETHNOPHARMACOLOGY

A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension

(2013) Gopinath Sutendra et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Astragaloside IV protects heart from ischemia and reperfusion injury via energy regulation mechanism

(2013) Lei Tu et al.   MICROCIRCULATION

Metabolomics Coupled with Proteomics Advancing Drug Discovery toward More Agile Development of Targeted Combination Therapies

(2013) Xijun Wang et al.   MOLECULAR & CELLULAR PROTEOMICS

Agonist-Induced Hypertrophy and Diastolic Dysfunction Are Associated With Selective Reduction in Glucose Oxidation

(2012) Jun Mori et al.   Circulation-Heart Failure

Metabolite Profiling and Pharmacokinetics of Herbal Compounds Following Oral Administration of a Cardiovascular Multi-herb Medicine (Qishen Yiqi Pills) in Rats

(2012) Yufeng Zhang et al.   CURRENT DRUG METABOLISM

Cardiac metabolism in hypertrophy and heart failure: implications for therapy

(2012) N. Siddiqi et al.   HEART FAILURE REVIEWS

QiShenYiQi Pills® prevents cardiac ischemia–reperfusion injury via energy modulation

(2012) Se-Qi Lin et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Mitochondria in cardiac hypertrophy and heart failure

(2012) Mariana G. Rosca et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Cardiac-Specific Over-Expression of Epidermal Growth Factor Receptor 2 (ErbB2) Induces Pro-Survival Pathways and Hypertrophic Cardiomyopathy in Mice

(2012) Polina Sysa-Shah et al.   PLoS One

Oxidative stress and cardiac hypertrophy: a review

(2012) Subir Kumar Maulik et al.   TOXICOLOGY MECHANISMS AND METHODS

Development of fluorescence imaging-based assay for screening cardioprotective compounds from medicinal plants

(2011) Yi Wang et al.   ANALYTICA CHIMICA ACTA

Glucose metabolism and cardiac hypertrophy

(2011) S. C. Kolwicz et al.   CARDIOVASCULAR RESEARCH

IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a

(2011) Yinan Hua et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats

(2011) Yiqun Tang et al.   PHYTOMEDICINE

Pressure Overload

(2011) Edward D. Frohlich et al.   Heart Failure Clinics

Dioxin-Sensitive Proteins in Differentiating Osteoblasts: Effects on Bone Formation In Vitro

(2009) Donatella Carpi et al.   TOXICOLOGICAL SCIENCES

Cardiac phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxia

(2008) Qianwen Wang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Myocardial adaptation of energy metabolism to elevated preload depends on calcineurin activity

(2008) Peter Schott et al.   BASIC RESEARCH IN CARDIOLOGY

Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate intervention

(2008) C.E. Huggins et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia

(2008) L. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA